Sinphar Pharmaceutical Co Ltd
TWSE:1734
Wall Street
Price Targets
Price Targets Summary
Sinphar Pharmaceutical Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Sinphar Pharmaceutical Co Ltd's stock price target?
Not Available
Sinphar Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Sinphar Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Sinphar Pharmaceutical Co Ltd's revenue is
4%.
The projected
CAGR
for the next 2 years is
6%.
What is Sinphar Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
16%
For the last 13 years the
compound annual growth rate for
Sinphar Pharmaceutical Co Ltd's operating income is
13%.
The projected
CAGR
for the next 2 years is
16%.
What is Sinphar Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
18%
For the last 13 years the
compound annual growth rate for
Sinphar Pharmaceutical Co Ltd's net income is
12%.
The projected
CAGR
for the next 2 years is
18%.
